Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.
de Oliveira Junior, Edilson Ribeiro
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society 05 2020 - 540-552 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4995
10.1016/j.jconrel.2020.02.033 doi
Acyclic Monoterpenes--administration & dosage
Administration, Intranasal
Animals
Antiparkinson Agents--administration & dosage
Parkinson Disease--drug therapy
Rats
Ursodeoxycholic Acid--administration & dosage
Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society 05 2020 - 540-552 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-4995
10.1016/j.jconrel.2020.02.033 doi
Acyclic Monoterpenes--administration & dosage
Administration, Intranasal
Animals
Antiparkinson Agents--administration & dosage
Parkinson Disease--drug therapy
Rats
Ursodeoxycholic Acid--administration & dosage